Archives

Speyside Equity Advisers - a private equity firm that invests in middle-market, buyout transactions in the manufacturing and value-added distribution sectors - announced that it has completed the acquisition of GSC Technologies. The deal will enable Speyside's continued investment in GSC and fuel the company's next growth phase. GSC is a leading manufacturer of plastic goods in North America.

ControlMonkey, an end-to-end cloud automation platform offering "Total Cloud Control with Terraform," announced its global launch and the close of a $7 million seed round, co-led by lool ventures and Joule Ventures. This funding round will accelerate the development of ControlMonkey's cloud governance tools and expand its global operations, including significant investments in engineering, customer success, and go-to-market initiatives.

Rockfish Data, a leader in synthetic data generation for operational workflows, announced the closing of a $4 million seed fundraising round. This funding round was led by Emergent Ventures with participation from Foster Ventures, TEN13, Dallas VC, NewBuild Venture Capital, and others. This brings the total amount raised close to $6 million.

Electric vehicle (EV) merchandising solution Lyteflo announced $3 million in seed funding. Launched by Ryan Osten (CEO) and Dominick Rivard (CTO), Lyteflo seamlessly integrates into dealership websites to help auto dealers move their EV inventory faster and appraise EV batteries with precision: a one-stop shop to help dealerships win the electric future. And Diagram led the oversubscribed round, with participation from Whitecap Venture Partners and Amplify Capital.

Netradyne, a SaaS provider of artificial intelligence (AI) and edge computing, announced closing a $90 million Series D round led by Point72 Private Investments with participation from Qualcomm Ventures and Pavilion Capital. The funding will accelerate the company’s growth trajectory through strategic investment in R&D, enhanced go-to-market investments, and aggressive global expansion, solidifying Netradyne as a worldwide industry leader in commercial fleet technology.

Coram AI, an innovator in LLM-powered video security, announced it raised $13.8 million in Series A funding in a round led by Battery Ventures. And existing investors 8VC and Mosaic Ventures also participated in the round.

Leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence, and Trinity Health, announced the Truveta Genome Project, which is an innovative collaboration to generate genetic data on tens of millions of consented and de-identified volunteers, creating the largest and most diverse database of genotypic and phenotypic information ever assembled. For this initiative, 17 health systems, including Regeneron and Illumina, have invested $320 million in Truveta preferred equity at a valuation exceeding $1 billion. As part of this deal, Regeneron has made a strategic investment of $119.5 million upfront (as part of Truveta’s Series C financing round), enabling the advancement of discovery and development of new therapies and the development of next-generation solutions for healthcare delivery and population health management. And Illumina, a global leader in DNA sequencing and array-based technologies, will invest $20 million. This builds on the previously announced strategic investment Microsoft made into Truveta.

Reown (previously known as WalletConnect) announced it has closed a $13 million Series B funding round. USV and 1kx led the funding round and it also included Global Digital Asset Holdings (a joint venture investment vehicle established by SC Ventures and SBI Holdings), Shopify Ventures, Kraken Ventures, Crypto.com Capital, Figment, Kiln, Everstake, BitGo Ventures, and Fenbushi. So far, Reown has raised a total of $38 million from some of the most prominent investors in Web 2 and web3.

Light Horse Therapeutics - a developer of first-in-class small molecule therapeutics - announced a $62 million Series A funding round. This funding was led by founding investor Versant Ventures and included Mubadala Capital as well as three strategic investors: Bristol-Myers Squibb Co, Taiho Ventures, and AbbVie. And Light Horse is the latest company started by Versant’s Inception Discovery Engine, and its scientific co-founders are Brian Liau, PhD, Ben Cravatt, PhD, and Nathanael Gray, PhD.

eBay announced that it has agreed to acquire Caramel, an end-to-end online automotive transaction solution provider. Caramel's technology platform provides a secure and seamless digital transaction experience that handles all of the complexities of a vehicle sale, including paperwork, ownership transfer, financing, transportation, and more, whether using on Caramel's site or app, through an independent dealer, or via Caramel's multiple marketplace and auction partners.

Lead Ninja is a company that aims to elevate HVAC, plumbing, and electrical technicians and businesses by providing the tools, training, and strategies to get ahead of the competition. Pulse 2.0 interviewed Lead Ninja CEO Gene Slade to learn more about the company.

A few months ago, leading customer success platform Gainsight partnered with multinational software company SAP to deliver a powerful integration between Gainsight CS and SAP Sales Cloud. This integration helps businesses transform how they deliver value-driven customer experiences at scale to maximize customer retention and revenue growth. Pulse 2.0 interviewed Gainsight President and COO Chuck Ganapathi and SAP’s Senior Vice President of CX Solution Management Nitin Badjatia to learn more about their partnership.

Tide is transformative and true-zero-trust technology, enabling platform developers to lock their systems and grant access with keys no one will ever hold. Pulse 2.0 interviewed Tide co-founder Yuval Hertzog to learn more about the organization.

Mavely is a Social Commerce platform that unlocks trust between your brand and its target audience. Pulse 2.0 interviewed Mavely co-founder Evan Wray to learn more about the company.

Leading insurance technology platform Matic Insurance Services announced it has secured $30 million from Vistara Growth, a provider of flexible growth capital to software and technology enabled services companies. And Matic offers an embedded insurance platform to mortgage servicers, originators, banks and other financial institutions to seamlessly offer home, auto, and other personal lines products to their customers.

Neumirna Therapeutics - an RNA-focused biotech company developing next-generation therapeutics for neurological disorders - announced the first closing of its Series A funding round at €20 million. New investors Angelini Ventures and Invivo Partners co-led the funding, with significant participation from Neumirna’s seed investor, Innovestor’s Life Science Fund, and other investors.

Coave Therapeutics - a company advancing the future of genetic medicines - announced the raising of €32 million ($33 million) in Series A funding. The funding was co-led by Novo Holdings A/S and Bpifrance, with Invus and UI Investissement participation alongside existing investors Seroba Life Sciences, Fund+, Kurma Partners, Omnes Capital, and Turenne Capital.

KashKick is a consumer rewards program that engages its audience through game challenges, consumer product deals, and market research opportunities. Pulse 2.0 interviewed Kashkick co-founder and CEO Vishal Mahtani to learn more about the company.

Deep Vector, an AI-based platform for analyzing underwriting documents, announced it closed a seed round of $1.5 million, co-led by Aperture Venture Capital and InsurTech NY. And Deep Vector helps insurers and brokers translate the influx of analog documents used for underwriting risk: claims loss runs, Acord forms, motor vehicle records, and business records into usable and actionable data.

PrettyDamnQuick (PDQ), an operational data platform for profitable commerce, announced that it closed a $25 million Series A funding round led by Peakspan Capital, with participation from existing investors TLV Partners and Moneta. And PDQ will utilize the funds to expand its market presence and accelerate the development of its cutting-edge checkout and shipping personalization engine, which helps mid-sized Direct-to-Consumer (D2C) e-commerce brands to boost revenue and compete more effectively with massive global entities like Amazon. So far, PDQ has raised $38 million.

Abstract, an artificial intelligence company developing the first regulatory superintelligence platform, announced it raised $4.8 million in seed funding co-led by Bonfire Ventures and Communitas Capital. This latest funding round brings Abstract’s total funding to over $9 million.

Qventus, a provider of AI-based care automation software for health systems, announced a $105 million investment led by KKR, with additional participation from renowned investment firm Bessemer Venture Partners, and new strategic investors, including leading health systems Northwestern Medicine, HonorHealth, and Allina Health. And this funding follows a year of significant growth for Qventus, increasing its cadre of health system partners and expanding its team globally.

Labviva, a leading AI procurement platform for life sciences, announced the closing of its $25 million Series B, bringing the total funding to $55 million. The round was led by 53 Stations, with continued participation from Biospring Partners, B Capital Group, and Glasswing Ventures. And the funding reflects the company’s boom growth and escalating demand in Biopharma for automated supply chain and procurement solutions. In connection with the funding round, 53 Station’s co-founder and Managing Partner, Jason Pritzker, will join Labviva’s Board of Directors.

Clear Labs, a provider of fully automated and next-generation sequencing (NGS) platforms for turnkey diagnostics, announced it has raised $30 million in its Series D financing. This funding round was led by a strategic investor, along with participation from existing investors, including Counterpoint Global (Morgan Stanley), Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, Redmile Group, Wing Venture Capital, and funds and accounts advised by T. Rowe Price Associates.

Red Sky Health (RSH), an AI-based platform designed to optimize healthcare claims management, announced it has raised $3 million in seed funding. The funding round was led by serial entrepreneur and investor Trevor Burgess, along with notable alumni from Charles River Data, Gleb Drobkov, and Mike Dezube, now key figures in Neptune Flood's data science leadership.

Telix Pharmaceuticals announced it has entered into an asset purchase agreement with antibody engineering company ImaginAb to buy a pipeline of next-generation therapeutic candidates, a proprietary novel biologics technology platform, and a protein engineering and discovery research facility to enhance existing innovation capabilities.

Lantheus Holdings, a leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced a definitive agreement to acquire Life Molecular Imaging in an all-cash transaction consisting of an upfront payment of $350 million and up to an additional $400 million in potential earn-out and milestone payments. And Life Molecular, a Life Healthcare Group Holdings subsidiary, is dedicated to advancing novel Positron Emission Tomography (PET) radiopharmaceutical diagnostics.

Global alternative asset management firm TPG announced that Kathy Elsesser has joined its Board of Directors as an independent director, effective immediately.

DIRECTV announced it acquired the majority ownership of INVIDI Technologies, a leader in addressable television advertising solutions that increase the value of advertising inventory for programmers and distributors by enabling marketers to target specific audiences on television without wasting ad impressions.

Global law firm Clifford Chance announced the appointment of leading Private Equity Partner Bruce Embley, based in London, as part of the firm's ambitious global Private Capital growth strategy. And Embley brings extensive experience advising on high-profile and complex private capital transactions for market leading clients.